KK
ROIV icon

KLP Kapitalforvaltning’s Roivant Sciences ROIV Stock Holding History

KLP Kapitalforvaltning’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
109,200
+26,500
+32% +$783K 0.01% 556
2026
Q1 		$2.29M Buy
82,700
+2,600
+3% +$66.8K 0.01% 662
2025
Q4 		$1.74M Buy
80,100
+4,000
+5% +$78.9K 0.01% 772
2025
Q3 		$1.15M Hold
76,100
– – ﹤0.01% 948
2025
Q2 		$858K Buy
76,100
+4,700
+7% +$50.9K ﹤0.01% 1065
2025
Q1 		$720K Sell
71,400
-6,200
-8% -$67K ﹤0.01% 1107
2024
Q4 		$918K Buy
+77,600
New +$917K ﹤0.01% 1037

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

KLP Kapitalforvaltning's ROIV Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Roivant Sciences (ROIV) stake by 32% in Q2 2026, buying an estimated $783K and bringing the position to 109,200 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #556.

KLP Kapitalforvaltning first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • KLP Kapitalforvaltning held 109,200 shares of Roivant Sciences worth $3.86M as of Q2 2026.
  • KLP Kapitalforvaltning bought 26,500 Roivant Sciences shares in Q2 2026, an estimated $783K.
  • Roivant Sciences made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #556 holding.
  • KLP Kapitalforvaltning first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.